(ALKS) Alkermes - Performance 22% in 12m
Compare ALKS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
69.65%
#7 in Group
Rel. Strength
77.03%
#1756 in Universe
Total Return 12m
21.96%
#32 in Group
Total Return 5y
115.51%
#22 in Group
P/E 15.1
50th Percentile in Group
P/E Forward 19.8
66th Percentile in Group
PEG -1,057.29
0th Percentile in Group
FCF Yield 8.21%
94th Percentile in Group
12m Total Return: ALKS (22%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: ALKS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALKS
Total Return (including Dividends) | ALKS | XBI | S&P 500 |
---|---|---|---|
1 Month | -4.28% | -5.85% | -3.01% |
3 Months | 13.57% | -11.95% | -3.15% |
12 Months | 21.96% | -11.00% | 10.19% |
5 Years | 115.51% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | ALKS | XBI | S&P 500 |
1 Month | -69.4% | -59.8% | -5.5% |
3 Months | 69.0% | -70.5% | -58.4% |
12 Months | 91.8% | -6.9% | 84.1% |
5 Years | 65.4% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #69 | 1.66% | -1.31% |
3 Month | #24 | 29.0% | 17.3% |
12 Month | #31 | 37.0% | 10.7% |
5 Years | #22 | 114% | -5.99% |
FAQs
Does ALKS Alkermes outperforms the market?
Yes,
over the last 12 months ALKS made 21.96%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months ALKS made 13.57%, while XBI made -11.95%.
Over the last 3 months ALKS made 13.57%, while XBI made -11.95%.
Performance Comparison ALKS vs Indeces and Sectors
ALKS vs. Indices ALKS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.37% | -1.27% | 12.7% | 11.8% |
US NASDAQ 100 | QQQ | -1.39% | -0.22% | 13.5% | 13.4% |
US Dow Jones Industrial 30 | DIA | -2.57% | -2.14% | 11.8% | 12.5% |
German DAX 40 | DAX | -1.07% | -0.90% | -4.07% | 0.27% |
Shanghai Shenzhen CSI 300 | CSI 300 | -2.08% | -4.51% | 28.0% | 12.8% |
Hongkong Hang Seng | HSI | -4.34% | -7.05% | 21.9% | 4.63% |
India NIFTY 50 | INDA | -3.40% | -12.2% | 23.1% | 21.3% |
Brasil Bovespa | EWZ | -2.48% | -12.6% | 20.7% | 33.7% |
ALKS vs. Sectors ALKS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.83% | -0.47% | 4.61% | 2.75% |
Consumer Discretionary | XLY | -3.13% | -0.45% | 9.36% | 7.90% |
Consumer Staples | XLP | -5.16% | -2.44% | 11.9% | 10.9% |
Energy | XLE | -3.46% | -12.3% | 7.14% | 21.2% |
Financial | XLF | -2.85% | -1.58% | 0.56% | -0.29% |
Health Care | XLV | -2.79% | -1.12% | 17.4% | 20.3% |
Industrial | XLI | -2.68% | -3.59% | 13.4% | 13.4% |
Materials | XLB | -3.47% | -4.79% | 20.8% | 25.9% |
Real Estate | XLRE | -4.41% | -1.59% | 15.8% | 8.60% |
Technology | XLK | -1.24% | -0.27% | 17.8% | 20.0% |
Utilities | XLU | -5.66% | -5.10% | 13.6% | -3.27% |
Aerospace & Defense | XAR | -1.77% | -5.56% | 8.80% | 1.03% |
Biotech | XBI | 2.19% | 1.57% | 30.4% | 33.0% |
Homebuilder | XHB | -2.87% | -4.43% | 32.1% | 29.7% |
Retail | XRT | -4.67% | -3.78% | 16.8% | 26.8% |